Hints and tips:
Related Special Reports
...BioNTech [also] doesn’t have any other products so it’s a lot of cash to have to pay,” said Christopher Sharp, an IP lawyer at Pinsent Masons....
...One banker who advised Arm on the deal said pitching an IPO to investors on a company that develops IP and architectures for chips was “not easy”....
...Large pharmaceutical companies that lagged behind in the race for the vaccine are now investing heavily in mRNA, including Sanofi, which bought Translate Bio for $3.2bn in 2021, and GSK, which is partnering...
...Arm is the world’s leading mobile processor IP provider — present in more than 95 per cent of global smartphones But strategic weaknesses remain in key areas… Chip design capability remains limited in...
...It is sharply written with mature themes and thoughtful plotting and paved the way for last year’s Arcane....
...Its shares have nearly tripled in the past two years, giving it a steep valuation that would make little sense for a mature business — its price to estimated 2021 earnings is 150 times....
...Hudson’s plan for Sanofi has been to scale back in mature markets such as treatments for cardiovascular and diabetes and expand in more attractive areas such as cancer and speciality drugs....
...It is the only one of the pre-pandemic big four vaccine makers currently selling a shot: Sanofi and GSK have not yet reported their phase 3 data after a dosing mistake set back an earlier trial of their...
...IP is not the limiting factor at this stage, says David Loew, executive vice-president at Sanofi Pasteur. “Most vaccines don’t even have IP....
...France’s Sanofi, for example, is collaborating with the UK’s GlaxoSmithKline to develop a vaccine....
...But she is content to see the technology mature elsewhere since Kef’s products, like many others from hi-fi brands, do not require an embedded voice assistant microphone....
...In particular, as the portfolio matures our business is approaching self-sustainability.” IP Group’s share price has fallen 44 per cent since the start of the year. Mr Woodford declined to comment....
...Zhang Lelin fears that Chinese engineers jumping from US to Chinese firms might trigger suspicions within their company or the FBI over IP theft....
...We expect F/W volume contraction as MONC focuses on profitability (possible Gross Mg mid-70s again, EBIT pre-IP at 29%) but still 24% below H219....
...IP Group blamed him earlier this month for a fall in value of its portfolio....
...also prevent expensive mistakes or disputes when the company matures and the stakes are even higher....
...Now, he says they are taking a “much more mature approach”....
...This IT services business is on 17.1x consensus CY20 EBITDA vs the gaming names (majority IP-led) on 16.9x and IT services on 10.9x. Sell. What else? Diageo warns mildly on sales. ......
...We believe Wagamama is a strong, mature concept. The main issues are: the price paid, the high level of gearing for a labour-intensive, leasehold business, and large execution risk....
...“It has allowed us to mature the IP for the last four years,” he added. Mr Finney said he remained optimistic about the future for Britain’s space industry despite the uncertainties over Brexit....
...Other partnerships include AstraZeneca’s and Sanofi’s projects with Berg, and Merck’s work with Numerate, another drug design company....
...“There are more collaborations these days but that’s really a reflection of the fact that our technologies are more mature.”...
...“The games industry has entered a mature period and no longer sees wild growth.” It is a lament repeated across the internet spectrum....
...2006 led him to found the Center for iPS Cell Research and Application, an organisation devoted to regenerative medicine research....
...Given occupancy rates in mature WeWork locations, defined as being open eighteen months, are near-90 per cent, and overall occupancy is 81 per cent, one would imagine a portion larger than 3 per cent of...
International Edition